title: [Treatment of bronchial asthma and COPD].
abstract: 4 clinical phenotypes can be differentiated in asthma and COPD. Apart from routine treatment strategies, phenotyp-specific options in treatment are important to optimise therapy in these patients. Identification of phenotypes and re-evaluation of patients not responding to treatment in the practitioners practise belong in the hand of the pneumologist as well as treatment of severe asthma. Acute severe asthma attacks have become rare in Swiss hospitals. Despite this progress, asthma control in our patients can still be improved. In COPD, any effort of primary respectively secondary smoking prevention is important.
authors.affiliation: Abteilung für Innere Medizin und Pneumologie, Zürcher Höhenklinik Davos.
authors.forename: Thomas
authors.initials: T
authors.lastname: Rothe
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D001249:Asthma / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003299:Cooperative Behavior; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D033183:Interdisciplinary Communication; D010641:Phenotype; D029424:Pulmonary Disease, Chronic Obstructive / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D013557:Switzerland
chemical_list: D000305:Adrenal Cortex Hormones; D000888:Antibodies, Anti-Idiotypic; D001993:Bronchodilator Agents; C026408:anti-IgE antibodies; D007073:Immunoglobulin E